feed,title,long_url,short_url
Benzinga,Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial,https://benzinga.com/general/biotech/21/11/24046285/eisai-posts-new-lecanemab-data-from-mid-stage-alzheimers-trial,https://j.mp/3n3WTZK
Benzinga,"Why Nio's 2022 Outlook Remains Solid, According To Mizuho",https://benzinga.com/analyst-ratings/analyst-color/21/11/24044249/why-nios-2022-outlook-remains-solid-according-to-mizuho,https://j.mp/31XF2vz
